Cancers,
Год журнала:
2024,
Номер
16(23), С. 4095 - 4095
Опубликована: Дек. 6, 2024
Pancreatic
ductal
adenocarcinoma
(PDAC)
stands
as
one
of
the
most
lethal
cancers,
marked
by
rapid
progression,
pronounced
chemoresistance,
and
a
complex
network
genetic
epigenetic
dysregulation.
Within
this
challenging
context,
sirtuins,
NAD
Catalysts,
Год журнала:
2025,
Номер
15(1), С. 37 - 37
Опубликована: Янв. 3, 2025
Nicotinamide
mononucleotide
(NMN)
has
emerged
as
a
promising
non-natural
cofactor
with
significant
potential
to
transform
biocatalysis,
synthetic
biology,
and
therapeutic
applications.
By
modulating
NAD⁺
metabolism,
NMN
offers
unique
advantages
in
enzymatic
reactions,
metabolic
engineering,
regenerative
medicine.
This
review
provides
comprehensive
analysis
of
NMN’s
biochemical
properties,
mechanisms
action,
diverse
Emphasis
is
placed
on
its
role
addressing
challenges
multi-enzyme
cascades,
biofuel
production,
the
synthesis
high-value
chemicals.
The
paper
also
highlights
critical
research
gaps,
including
need
for
scalable
methods,
improved
integration
into
systems,
toxicity
studies
use.
Emerging
technologies
such
AI-driven
enzyme
design
CRISPR-based
genome
engineering
are
discussed
transformative
tools
optimizing
NMN-dependent
pathways.
Furthermore,
synergistic
biology
innovations,
cell-free
systems
dynamic
regulatory
networks,
explored,
paving
way
precise
modular
biotechnological
solutions.
Looking
forward,
versatility
positions
it
pivotal
tool
advancing
sustainable
bioprocessing
precision
Addressing
current
limitations
through
interdisciplinary
approaches
will
enable
redefine
boundaries
innovation.
serves
roadmap
leveraging
across
scientific
industrial
domains.
Frontiers in Cell and Developmental Biology,
Год журнала:
2025,
Номер
13
Опубликована: Фев. 4, 2025
Gastric
cancer
(GC)
is
one
of
the
most
common
and
highly
lethal
malignant
tumors
worldwide,
its
occurrence
development
are
regulated
by
multiple
molecular
mechanisms.
Post-translational
modifications
(PTM)
forms
include
ubiquitylation,
phosphorylation,
acetylation
methylation.
Emerging
research
has
highlighted
lactylation
glycosylation.
The
diverse
realm
PTM
crosstalk
linked
to
many
critical
signaling
events
involved
in
neoplastic
transformation,
carcinogenesis
metastasis.
This
review
provides
a
comprehensive
overview
impact
on
progression
GC.
Specifically,
aberrant
have
been
shown
alter
proliferation,
migration,
invasion
capabilities
GC
cells.
Moreover,
closely
associated
with
resistance
chemotherapeutic
agents
Notably,
this
also
discusses
phenomenon
crosstalk,
highlighting
interactions
among
their
roles
regulating
pathways
protein
functions.
Therefore,
in-depth
investigation
into
mechanisms
targeted
therapeutic
strategies
hold
promise
for
advancing
early
diagnosis,
treatment,
prognostic
evaluation
GC,
offering
novel
insights
future
directions.
Epigenomes,
Год журнала:
2025,
Номер
9(1), С. 5 - 5
Опубликована: Фев. 5, 2025
Genomic
and
epigenomic
instability
are
defining
features
of
cancer,
driving
tumor
progression,
heterogeneity,
therapeutic
resistance.
Central
to
this
process
epigenetic
echoes,
persistent
dynamic
modifications
in
DNA
methylation,
histone
modifications,
non-coding
RNA
regulation,
chromatin
remodeling
that
mirror
underlying
genomic
chaos
actively
influence
cancer
cell
behavior.
This
review
delves
into
the
complex
relationship
between
these
illustrating
how
they
collectively
shape
genome,
affect
repair
mechanisms,
contribute
evolution.
However,
dynamic,
context-dependent
nature
changes
presents
scientific
ethical
challenges,
particularly
concerning
privacy
clinical
applicability.
Focusing
on
lung
we
examine
specific
patterns
function
as
biomarkers
for
distinguishing
subtypes
monitoring
disease
progression
relapse.
Journal of Enzyme Inhibition and Medicinal Chemistry,
Год журнала:
2025,
Номер
40(1)
Опубликована: Фев. 12, 2025
Sirtuins
(SIRTs)
are
NAD+-dependent
histone
deacetylases,
which
play
a
key
role
in
cancer
progression;
however,
their
prognostic
values
breast
(BC)
remain
subject
of
debate
and
controversy.
Accumulative
evidence
suggests
that
each
sirtuin
possesses
individual
character,
implicating
its
the
regulation
multifaceted
biological
functions
leading
to
BC
initiation,
progression
metastasis.
Selisistat
(EX527)
is
potent,
cell
permeable,
highly
selective
SIRT1
inhibitor.
In
study,
tumour-suppressive
effects
inhibitor
EX527
(selisistat)
alone
combination
with
paclitaxel
(PAX)
different
lines
zebrafish
xenograft
models
were
investigated.
The
type
pharmacological
drug-drug
interaction
between
PAX
was
determined
using
isobolographic
method.
used
individually
inhibited
proliferation,
induced
apoptosis
caused
cycle
arrest
G1
subG1/G2
phases.
Interestingly,
these
compounds
1:1
dose-ratio
augmented
all
(IC50add
29.52
±
3.29
−
38.45
5.26).
co-treatment
generated
desirable
additive
interaction.
simultaneous
application
stronger
inhibition
tumour
growth
compared
treatments
xenografts.
silico
analysis
revealed
protein-protein
pathway
(SIRT1-AKT-S1PR1-GNAI1/GNAO1-Tubulin)
connecting
molecular
targets
both
ligands.
To
summarise,
more
effectively
impairs
treatments.
However,
further
investigations
required
clarify
specific
mechanisms
underlying
activity
EX527:PAX
other
preclinical
models.
Cells,
Год журнала:
2025,
Номер
14(6), С. 466 - 466
Опубликована: Март 20, 2025
Metabolic
dysfunction
leading
to
non-alcoholic
fatty
liver
disease
(NAFLD)
exhibits
distinct
molecular
and
immune
signatures
that
are
influenced
by
factors
like
gut
microbiota.
The
microbiome
interacts
with
the
via
a
bidirectional
relationship
gut–liver
axis.
Microbial
metabolites,
sirtuins,
responses
pivotal
in
different
metabolic
diseases.
This
extensive
review
explores
complex
multifaceted
interrelationship
between
sirtuins
microbiota,
highlighting
their
importance
health
disease,
particularly
hepatocellular
carcinoma
(HCC).
Sirtuins
(SIRTs),
classified
as
group
of
NAD+-dependent
deacetylases,
serve
crucial
modulators
wide
spectrum
cellular
functions,
including
pathways,
inflammatory
response,
process
senescence.
Their
subcellular
localization
diverse
functions
link
them
various
conditions,
NAFLD
cancer.
Concurrently,
comprising
microorganisms,
significantly
influences
host
metabolism
responses.
Recent
findings
indicate
modulate
microbiota
composition
function,
while
can
affect
sirtuin
activity.
is
relevant
disorders,
where
dysbiosis
contributes
progression.
highlights
recent
on
roles
specific
maintaining
implications
HCC
development.
Understanding
these
interactions
offers
potential
therapeutic
avenues
for
managing
diseases
linked
dysregulation
pathology.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(16), С. 9125 - 9125
Опубликована: Авг. 22, 2024
Sirtuin
5
(SIRT5)
is
increasingly
recognized
as
a
key
regulator
of
cellular
metabolism,
which
commonly
dysregulated
in
cancer
cells,
resulting
enhanced
proliferation
and
tumor
progression.
To
investigate
the
clinicopathologic
implications
SIRT5
dysregulation
glioblastoma,
we
performed
comprehensive
analyses
transcriptomic
data
functional
verifications
using
vitro
vivo
glioblastoma
models.
We
found
that
higher
expression
levels
were
associated
with
favorable
prognosis
glioma
patients.
Knockdown
significantly
cell
growth.
Our
suggest
its
potential
role
regulating
mitochondrial
metabolism
gliomas.
Furthermore,
also
correlated
synaptic
remodeling
pathways.
findings
indicate
tumor-suppressive
for
extends
beyond
by
it
may
function
through
modulating
neuroplasticity.
Understanding
these
interactions
provides
nuanced
insights
into
multifaceted
broader
therapeutic
this
development
novel
treatment
strategies.
International Journal of Translational Medicine,
Год журнала:
2024,
Номер
4(4), С. 687 - 709
Опубликована: Дек. 2, 2024
Sirtuins
are
a
family
of
lysine
deacetylases
that
regulate
cellular
homeostasis
and
energy
sensing.
Regeneration
is
the
process
restores
structural
functional
at
cellular,
tissue,
organ,
appendage
levels.
Several
processes,
such
as
epithelial–mesenchymal
transition
(EMT),
proliferation,
migration,
differentiation,
contribute
to
restoration
after
an
injury.
This
review
highlights
role
sirtuins
in
anatomical
structure
regeneration,
showing
how
modulate
signalling
pathways
by
deacetylating
targets
transcription
factors.
Furthermore,
understanding
this
protein
could
help
elucidate
molecular
mechanisms
underlying
tissue
which
may
hold
significant
potential
for
fields
regenerative
medicine.
The
compiles
evidence
suggesting
emerging
factors
regeneration
various
organs
(e.g.,
skin,
liver,
heart)
tissues
bone,
muscle,
cornea,
spinal
cord).
Journal of Biochemical and Molecular Toxicology,
Год журнала:
2024,
Номер
38(11)
Опубликована: Окт. 18, 2024
Abstract
New
FOXM1‐specific
inhibitors
with
the
potential
to
be
used
for
therapeutic
purposes
are
under
extensive
research.
We
hypothesized
that
deacetylation
of
FOXM1
would
decrease
protein
expression,
thus
providing
novel
management
colon
cancers.
Immunostaining
was
determine
and
SIRT2
expressions
in
human
cancer
tissue
microarrays
(
n
=
90)
from
Stage
I
IV.
SIRT2‐FOXM1
interaction
evaluated
cells
using
immunoprecipitation.
Deacetylation
via
determined
vitro
assays.
could
hyper‐acetylated
when
p300
pCAF
histone
acetyltransferases
were
administered
alongside
deacetylase
inhibitors.
detected
physically
interacted,
deacetylated
vitro.
overexpression
led
a
significant
while
knockdown
increased
expression
HCT116
carcinoma
cells.
In
analysis
90
colorectal
samples,
high
observed
about
49%
cancer,
intermediate
29%,
low
or
no
staining
22%.
Strong
found
negatively
associated
our
clinical
cohort.
This
study
reveals
molecular
association
between
cell
lines
suggests
targeting
activity
small
molecule
modulators
may
promising
approach
cancer.
Biomolecules,
Год журнала:
2024,
Номер
14(12), С. 1512 - 1512
Опубликована: Ноя. 27, 2024
Actinic
keratosis
(AK)
is
a
precursor
to
invasive
squamous
cell
carcinoma,
making
early
diagnosis
and
treatment
essential
prevent
progression.
Among
available
therapeutic
options,
nicotinamide
(NAM)
has
shown
potential
in
reducing
AK
NAM
of
adenine
dinucleotide
(NAD+),
which
activates
sirtuin
(SIRT)1,
protein
with
anti-cancer
properties.
Although
the
role
SIRT1
still
debated,
no
data
currently
exist
on
systemic
modulation
this
AK.
Therefore,
study
aims
evaluate
whether
NAM,
by
increasing
serum
NAD+
levels,
may
promote
activation
peripheral
blood
mononuclear
cells
(PBMCs)
patients.
Thirty
patients
were
enrolled
treated
for
24
months.
Hematological,
biochemical,
skin
condition
assessments
conducted,
alongside
measurement
levels.
A
decrease
basophils,
monocytes,
total
cholesterol,
glucose
levels
was
observed
group,
along
reduction
lesions.
Notably,
significantly
enhanced
nuclear
activity
PBMCs.
In
conclusion,
administration
reduced
progression
NAD+/SIRT1-dependent
manner,
supporting
its
as
chemopreventive
agent
management.